From July 3 to July 6, 2022, ESHRE 38th Annual Meeting will be held in Milan, Italy.

The congress will be hosted at the Milano Convention Center (MiCo). Numerous high quality and interesting scientific presentations will take place throughout the congress. The program and more information can be found at:

www.eshre.eu/ESHRE2022

FERRING is once again a proud sponsor of the annual meeting of the European Society of Human Reproduction & Embryology (ESHRE). This year’s hybrid meeting features a high-interest program that includes new data, an extensive educational program, and the opportunity for you to participate in plenary sessions, debates, and panel discussions from world-leading experts. Learn more about what FERRING has planned at ESHRE.

If you have any questions, please do not hesitate to contact Ms. Tanja Hildmann at 0431 5852-222 oder or by email: tanja.hildmann@ferring.com.

With kind regards

Bianca Koens
FERRING Arzneimittel GmbH | Business Unit Director

the complete program
Add ESHRE to calendar

ESHRE 38th
Annual Meeting

www.eshre.eu
0
0
0
Weeks
0
0
0
0
Days
0
0
Hrs
0
0
Min
0
0
Sec

CONGRESS

Congress will take place on:

MONDAY 4 JULY

08.30 am – 06.00 pm

TUESDAY 5 JULY

08.30 am – 06.00 pm

WEDNESDAY 6 JULY

08.30 am – 04.30 pm

You can find the conference program at

www.eshre.eu

ABSTRACTS

From research to practice, new perspectives in treatment and more clarity in daily care – a wide variety of impressive abstracts were selected to be presented at ESHRE this year. For example:

  • Real-world evidence on treatment with follitropin delta in routine clinical practice.

  • New therapeutic perspectives by incorporating the individual patient profile and a dosing algorithm.

  • New insights into the effects of recombinant hCG on ovarian stimulation.

  • Causes of inaccurate estimates of success rates in women with ART.

the full list of abstracts

Symposium

We are building on the very good feedback from last year and going even deeper into the question with this year’s symposium: How can existing data be used to improve treatment outcomes?
Likewise, insights will be provided into the challenges faced by people wanting to start a family around the world. Also learn about Ferring’s commitment to improving patient care and access to treatment worldwide.

MAKING A DIFFERENCE IN THE REAL WORLD:

A LEGACY OF SCIENCE AND BEYOND

Tuesday, July 5, 2022, 11:45 – 13:00 CEST

11:45 – 12:05 a

New perspectives on hCG-driven LH bioactivity

Scott Nelson (UK)

12:05 – 12:25

Follitropin delta: A diversity of evidence and clinical experience

Georg Griesinger (Germany)

12:25 – 12:40

Real-world evidence and the experience of Follitropin delta:
A multicentre German experience

Alexandra Bielfeld (Germany)

12:40 – 13:00

Ferring: Driving solutions to improve care and access in reproductive medicine and maternal health

Per Falk (Ferring), Roberta Bulla (Italy)

Add SYMPOSIUM to calendar

INDUSTRIAL EXHIBITION

We look forward to seeing you at the Ferring exhibition at the ESHRE Annual Meeting in Milan! At the exhibition you will learn more about our commitment to reproductive medicine and maternal health.

REGISTRATION FOR ESHRE

July 3 – 6

Register here
the complete program
Add ESHRE to the calendar